In a setback for GlaxoSmithKline, the same federal judge who recently remanded eight Paxil birth defect suits to state court has now been assigned by his chief judge to decide the fate of another 21 cases despite GSK’s protests of "judge shopping."

"We disagree with defendant that it is unfair to transfer the motions to Judge [Timothy] Savage, who is extremely familiar with the issue involved and has already ruled on the motions in other Paxil cases," Chief Judge Harvey Bartle III wrote.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]